Backfunctionalized imidazolinium salts and NHC carbene-metal complexes

US10150738B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10150738-B2
Application numberUS-201715596780-A
CountryUS
Kind codeB2
Filing dateMay 16, 2017
Priority dateOct 9, 2014
Publication dateDec 11, 2018
Grant dateDec 11, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Backfunctionalized imidazolinium salts and methods of synthesizing the same and NHC carbene-metal complexes therefrom. For backfunctionalized imidazolinium salts of the formula: Wherein R 1 is selected from the group consisting of an ester group, an amide group, and an aromatic group; R 2 is selected from the group consisting of hydrogen, an ester group, an amide group, and an aromatic group; R 3 and R 4 are each an aliphatic group; and X is an anion; the method comprises cyclization of a halogenated acrylate with Hünig's base in a solvent.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of synthesizing a backfunctionalized imidazolinium salt comprising the formula: R 1 being selected from the group consisting of an ester group, an amide group, and an aromatic group; R 2 being selected from the group consisting of hydrogen, an ester group, an amide group, and an aromatic group; R 3 and R 4 are each an aliphatic group; and X is an anion, the method comprising: providing a halogenated acrylate or maleate having R 1 and R 2 groups; and cyclization of the halogenated acrylate with a primary base in a solvent and a formamidine complex having R 3 and R 4 groups, the primary base being Hünig's base. 2. The method of claim 1 , wherein the solvent is acetone or toluene. 3. The method of claim 1 , further comprising: introducing a secondary base during the cyclization. 4. The method of claim 3 , wherein the secondary base is triethylamine. 5. The method of claim 1 , wherein each of R 3 and R 4 is separately selected from the group consisting of a C1-C20 alkyl group, C1-C20 partially fluorinated alkyl group, an aryl group, an aryl group with para CF 3 functionality, an aryl group having C1-C20 partially fluorinated alkyl groups or partially fluorinated alkoxy groups, and a C1-C20 partially fluorinated aliphatic group, and a C1-C20 aryl group. 6. The method of claim 1 , wherein X is a halogen anion. 7. The method of claim 1 , wherein the R 1 group is in a trans-configuration with respect to the R 2 group. 8. The method of claim 1 , wherein the solvent is a polar aprotic solvent. 9. The method of claim 8 , wherein the polar aprotic solvent is selected from the group consisting of ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, and triethylene glycol dimethyl ether. 10. A method of synthesizing a backfunctionalized imidazolinium salt comprising the formula: R 1 being selected from the group consisting of an ester group, an amide group, and an aromatic group; R 2 being selected from the group consisting of hydrogen, an ester group, an amide group, and an aromatic group; R 3 and R 4 are each an aliphatic group; and X is an anion, the method comprising: providing a halogenated acrylate or maleate having R 1 and R 2 groups; and formamidine cyclization of a halogenated, fluorinated allyl ether with Hünig's base in polar aprotic solvent, the formamidine having R 3 and R 4 groups. 11. The method of claim 10 , further comprising: introducing a secondary base during the cyclization. 12. The method of claim 11 , wherein the secondary base is triethylamine. 13. The method of claim 10 , wherein each of R 3 and R 4 is separately selected from the group consisting of a C1-C20 alkyl group, C1-C20 partially fluorinated alkyl group, an aryl group, an aryl group with para CF 3 functionality, an aryl group having C1-C20 partially fluorinated alkyl groups or partially fluorinated alkoxy groups, and a C1-C20 partially fluorinated aliphatic group, and a C1-C20 aryl group. 14. The method of claim 10 , wherein the R 1 group is in a trans-configuration with respect to the R 2 group. 15. The method of claim 10 , wherein the polar aprotic solvent is selected from the group consisting of ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, and triethylene glycol dimethyl ether.

Assignees

Inventors

Classifications

  • Iridium compounds · CPC title

  • Ruthenium compounds · CPC title

  • C07D233/28Primary

    with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10150738B2 cover?
Backfunctionalized imidazolinium salts and methods of synthesizing the same and NHC carbene-metal complexes therefrom. For backfunctionalized imidazolinium salts of the formula: Wherein R 1 is selected from the group consisting of an ester group, an amide group, and an aromatic group; R 2 is selected from the group consisting of hydrogen, an ester group, an amide gr…
Who is the assignee on this patent?
Us Air Force
What technology area does this patent fall under?
Primary CPC classification C07D233/28. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).